IPFA/PEI 25th International Workshop on Surveillance and Screening of Blood-borne Pathogens

Blood-borne pathogens: Keeping the Blood Supply SafeThis 25th International Workshop on Blood-borne Pathogens will address the detection, inactivation and epidemiology of new and old agents, that threaten the safety of blood components and plasma derivatives, including the costs and regulation of safety interventions. The open and inclusive discussions between all stakeholders will also include contributions from researchers and colleagues beyond the immediate field of transfusion.

Eric Youssef
Associate Director
Plasma Initiative
Merck

Don’t miss our presentation:

Triton® X-100: Merck Strategy and Alternatives for Virus Inactivation

Thursday, May 17 at 9:40 am

This presentation will describe Merck’s strategy in response to the REACH announcement to ban Triton X 100 from industrial use.

The pharmaceutical industry is shifting to greener and more environmental friendly products and processes like many other industries.

In 2006 the European Union introduced the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). REACH is a chemicals regulation that aims to protect human health and the environment from the use of chemicals.

Substances of very high concern (SVHC) are identified as part of this regulation and certain mechanism of action may be taken by the authorities to limit the potential risks from their use.

Triton X -100 has been identified as one such (SVHC) chemical substance, having properties which are harmful to the environment. For this substance, the sunset date is the 4th of January 2021.

This presentation will describe Merck’s strategies for authorization and development of a potentially substitute agent for virus inactivation.